Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $22.00

Phibro Animal Health (NASDAQ:PAHC) had its target price increased by Barclays from $20.00 to $22.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an underweight rating on the stock.

A number of other equities analysts have also issued reports on the company. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $24.60 on Monday. Phibro Animal Health has a fifty-two week low of $11.24 and a fifty-two week high of $26.49. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.69 and a current ratio of 3.20. The company has a market cap of $996.30 million, a PE ratio of 51.25, a P/E/G ratio of 0.53 and a beta of 0.52. The business has a 50-day simple moving average of $22.01 and a two-hundred day simple moving average of $21.80.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, equities analysts expect that Phibro Animal Health will post 1.94 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.95%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors have recently modified their holdings of PAHC. Geode Capital Management LLC grew its holdings in Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after acquiring an additional 27,201 shares during the period. Barclays PLC boosted its position in Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Algert Global LLC grew its stake in shares of Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after purchasing an additional 59,850 shares during the period. FMR LLC increased its holdings in shares of Phibro Animal Health by 22.7% during the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after purchasing an additional 7,270 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.